New Catalyst Award Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
May 12, 2026
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Co-founded by Solve M.E., the World ME Alliance is a global collaboration of 27 organizations
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we know about
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
Dr. Karen Bonuck is professor of family and social medicine at Albert Einstein College of
A quick note to loop you in on another appropriations effort we’re in support of
We’re proud to announce that Solve CEO Emily Taylor has been selected for the 2026–2027
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Advocacy Week 2026 starts this Monday, March 23rd, and this year we’re doing something different.
Solve M.E. and #MEAction are joining forces for a week of coordinated action designed to